ProMIS Neurosciences (PMN) vs Stablecoin Development (SDEV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
ProMIS Neurosciences (PMN) has outperformed Stablecoin Development (SDEV) over the past year, losing 35.8% versus a loss of 66.8%. Over five years, PMN leads with a -95.9% price change compared with -99.9% for SDEV. ProMIS Neurosciences is the larger company by market cap ($86.2 million vs $79.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PMN | SDEV |
|---|---|---|
| Share price | $9.61 | $1.54 |
| Market cap | $86.18M | $79.70M |
| 1-day change | +5.03% | -22.61% |
| YTD return | +33.97% | -92.94% |
| 1-year return | -35.79% | -66.83% |
| 5-year return | -95.93% | -99.94% |
| EPS (TTM) | $-12.22 | $-16.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $27.40 | $99.75 |
| 52-week low | $6.27 | $0.78 |
| Distance from 52-week high | -64.93% | -98.46% |
| Analyst consensus | none | — |
| Avg. price target upside | +343.39% | — |
| Average volume | 83.76K | 11.93M |
| Shares outstanding | 8.97M | 51.75M |
| Employees | 10 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PMN has outperformed SDEV by 31.0 percentage points over the past year.
About ProMIS Neurosciences
PMN stock →ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
About Stablecoin Development
SDEV stock →Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
PMN vs SDEV FAQ
Which is bigger, ProMIS Neurosciences or Stablecoin Development?
ProMIS Neurosciences (PMN) is larger, with a market capitalization of $86.18M compared with $79.70M for Stablecoin Development (SDEV).
Which stock has performed better over the past year, PMN or SDEV?
PMN returned -35.79% over the past 12 months, compared with -66.83% for SDEV (price return, excluding dividends). Past performance does not predict future results.
Are ProMIS Neurosciences and Stablecoin Development in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.